4.5 Article

Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression

Journal

ONCOTARGETS AND THERAPY
Volume 12, Issue -, Pages 135-146

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/OTT.S186607

Keywords

DANCR; NSCLC; progression; biomarker

Funding

  1. Guidance Project of Zhenjiang Municipal Science and Technology Bureau [FZ2017038]
  2. Guidance Project of Nantong Municipal Science and Technology Bureau [HS13922]
  3. Foundation of Clinical Science and Technology of Wuxi [MS201609]

Ask authors/readers for more resources

Background: Long non-coding RNAs (lncRNAs) play important roles in human cancers. However, the functional roles of lncRNAs in non-small-cell lung cancer (NSCLC) and the underlying mechanisms are not well understood. Methods: We examined the expression of lncRNA DANCR in NSCLC by qRT-PCR and explored its biological roles in NSCLC progression by cell and molecular biology studies. Results: DANCR expression level was increased in human NSCLC. The knockdown of DANCR inhibited NSCLC cell proliferation by inducing cell apoptosis and cell cycle arrest. In addition, DANCR knockdown suppressed NSCLC cell migration and invasion via inhibition of epithelial-mesenchymal transition (EMT). On the contrary, DANCR overexpression had the opposite effects. DANCR knockdown inhibited EZH-2-mediated epigenetic silencing of p21 promoter and increased p21 expression. Moreover, DANCR knockdown inhibited NSCLC cell proliferation, migration, and invasion in a p21-dependent manner. Conclusion: DANCR plays oncogenic roles in NSCLC and may provide a novel biomarker for NSCLC diagnosis and prognosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available